Biosimilar Clinical Development: Scientific Considerations and New Methodologies

✍ Scribed by Kerry B. Barker, Sandeep M. Menon, Ralph B. D’Agostino Sr., Siyan Xu, Bo Jin (eds.)

Publisher: Chapman and Hall / CRC
Year: 2017
Tongue: English
Leaves: 269
Series: Chapman & Hall / CRC Biostatistics Series
Category: Library

No coin nor oath required. For personal study only.

✦ Synopsis

Biosimilars have the potential to change the way we think about, identify, and manage health problems. They are already impacting both clinical research and patient care, and this impact will only grow as our understanding and technologies improve. Written by a team of experienced specialists in clinical development, this book discusses various potential drug development strategies, the design and analysis of pharmacokinetics (PK) studies, and the design and analysis of efficacy studies.

✦ Subjects

Biostatistics;Biology;Biological Sciences;Science & Math;Probability & Statistics;Applied;Mathematics;Science & Math;Pharmacy;Pharmacology;Reference;Atlases;Dictionaries & Terminology;Drug Guides;Instruments & Supplies;Medicine & Health Sciences;New, Used & Rental Textbooks;Specialty Boutique;Pharmacy;Allied Health Services;Medicine & Health Sciences;New, Used & Rental Textbooks;Specialty Boutique;Pharmacology;Basic Sciences;Medicine;Medicine & Health Sciences;New, Used & Rental Textbooks;Specia

📜 SIMILAR VOLUMES

Biosimilar clinical development: scienti

✍ Kerry B. Barker, Sandeep M. Menon, Ralph B. D'Agostino Sr., Siyan Xu, Bo Jin P 📂 Library 📅 2017 🏛 Chapman and Hall/CRC 🌐 English

Biosimilars have the potential to change the way we think about, identify, and manage health problems. They are already impacting both clinical research and patient care, and this impact will only grow as our understanding and technologies improve. Written by a team of experienced specialists in

Methodologies in Biosimilar Product Deve

📁 Methodologies in Biosimilar Product Development

✍ Sang Joon Lee, Shein-Chung Chow 📂 Library 📅 2021 🏛 CRC Press/Chapman & Hall 🌐 English

Methodologies for Biosimilar Product Development covers the practical and challenging issues that are commonly encountered during the development, review, and approval of a proposed biosimilar product. These practical and challenging issues include, but are not limited to the m

Biosimilars: Regulatory, Clinical, and B

✍ Hiten J. Gutka, Harry Yang, Shefali Kakar 📂 Library 📅 2018 🏛 Springer International Publishing 🌐 English

This book provides a comprehensive overview of the biosimilar regulatory framework, the development process and clinical aspects for development of biosimilars. The development path of a biosimilar is just as unique as a development path of a new drug, tailored by the mechanism of action, the

World Englishes: New Theoretical and Met

📁 World Englishes: New Theoretical and Methodological Considerations

✍ Elena Seoane, Cristina Suárez-Gómez (eds.) 📂 Library 📅 2016 🏛 John Benjamins 🌐 English

This book provides a collection of articles that reflect the current state of affairs in the blossoming field of World Englishes by bringing together several innovative synchronic and diachronic approaches. It contributes to the ongoing theoretical discussion concerning the criteria that make a low-

Biosimilars of Monoclonal Antibodies: A

✍ Cheng Liu, K. John Morrow Jr. 📂 Library 📅 2017 🏛 Wiley-Interscience 🌐 English

Addressing a significant need by describing the science and process involved to develop biosimilars of monoclonal antibody (mAb) drugs, this book covers all aspects of biosimilar development: preclinical, clinical, regulatory, manufacturing. • Guides readers through the complex landscape i

Antisense-based drugs and therapeutics:

📁 Antisense-based drugs and therapeutics: preclinical and clinical considerations for development

✍ Ferrari, Nicolay; Seguin, Rosanne 📂 Library 📅 2016 🏛 John Wiley & Sons 🌐 English